GLP-1 Research Peptides: Complete Category Overview 2026

<p>GLP-1 (glucagon-like peptide-1) receptor agonism has emerged as one of the most active areas of peptide research and pharmaceutical development in the 21st century. The discovery that incretin peptides could drive insulin secretion in a glucose-dependent manner — avoiding the hypoglycemia risk of insulin secretagogues — fundamentally changed metabolic medicine research and has generated enormous scientific interest in the GLP-1 receptor pathway.</p><p>This overview covers the major GLP-1 and incretin-class research compounds, their mechanisms, and the published literature landscape.</p><h2>The GLP-1 Receptor: Biology Overview</h2><p>GLP-1R is a class B GPCR expressed in pancreatic beta cells, CNS neurons, cardiovascular tissue, kidney, and gastrointestinal tract. Activation by GLP-1 or synthetic agonists triggers Gs-mediated cAMP accumulation and downstream insulin secretion, glucagon suppression, gastric motility reduction, and satiety signaling. The diversity of GLP-1R expression sites explains the multi-system effects observed with GLP-1R agonists in both preclinical and clinical research.</p><h2>GLP-1 Compound Progression: Research Timeline</h2><p>GLP-1R agonist development has progressed through several generations:</p><ul><li>First generation: Exenatide — short-acting, required twice-daily dosing</li><li>Second generation: Liraglutide — daily dosing, first cardiovascular outcomes data</li><li>Third generation: GLP-1 (S) — once-weekly, highest single-agonist efficacy data</li><li>Fourth generation: TZ2 – GLP2 — dual GIP/GLP-1, superior clinical endpoints</li><li>Fifth generation (emerging): RT3 – GLP3 — triple GLP-1/GIP/GCGR; CagriSema — GLP-1 + amylin</li></ul><h2>TX Research Peptides GLP-1 Catalog</h2><ul><li>GLP-1 (S) — the GLP-1R reference standard</li><li>TZ2 – GLP2 — dual GIP/GLP-1 research compound</li><li>RT3 – GLP3 — triple-agonist GLP-1/GIP/GCGR</li><li>Cagrilintide — amylin analog complement to GLP-1R agonists</li></ul><p>Q: Which GLP-1 peptide should I use for my research?</p><p>A: The choice depends on which receptor pathway you're studying. GLP-1 (S) for isolated GLP-1R; TZ2 – GLP2 for dual GIP/GLP-1 comparison; RT3 – GLP3 for triple-receptor models; cagrilintide for amylin pathway research.</p><p>Related: TZ2 – GLP2 → | RT3 – GLP3 → | GLP-1 (S) → | Cagrilintide →</p>